Management, Scientific Advisors, and Clinical Advisors

  • Clet Niyikiza, PhD

    Founder & Executive Chairman

    Founder of LEAF4Life and Co-inventor of LEAF-4L6715. Former Executive VP of Development at Merrimack Pharmaceuticals. VP of Medicine Development Strategy at GlaxoSmithKline involved in the development of Tykerb®/Tyverb®. Research Fellow at Eli Lilly and Company. Involved in the development and registration of anticancer drugs ALIMTA®, GEMZAR® and EVISTA®. Sole inventor of U.S. Patent No. 7,772,209, which was seminal for the commercial success of Lilly’s ALIMTA® with over 34 Billion USD in total revenue before patent expiration in 2022.

  • Hans C. Kastensmith

    Healthcare & Venture Capital

    Managing Partner at Capitol Health Associates. Founder and President of I-Trax Medical Solutions (Amex: DMX). Operating Partner at Match Point Partners. Former CEO of six healthcare companies. Subject matter expert on healthcare policy, advising the U.S. Congress on critical healthcare issues.

  • Dr. Victor Moyo, MD

    Hematology & Oncology

    Co-Inventor of LEAF-4L6715, Former EVP, CMO and Head of R&D for both LEAF4Life and L.E.A.F. Pharmaceuticals; Former VP of Clinical Investigations, Merrimack – Developed Onivyde ®, a new pancreatic cancer drug sold for over $2B USD cumulatively. Former Medical Director at Johnson and Johnson-JNJ (DOXIL®) and previously Assistant Professor at University of Connecticut Health Center. Currently serving as Oncology CMO ; Traws Pharma Inc (Nasdaq TRAW).

  • Prof. Xavier Pivot, MD, PhD

    Oncology

    General Director of Strasbourg Institute of Cancer (ICANS), Strasbourg, France, Former Chairman of the Oncology Department at the Hospital University of Besançon, France.

  • Dr. Daniel Von Hoff, MD, FACP

    Genomics

    Physician in Chief, Distinguished Translational Research Division at Translational Genomics Research Institute (TGen) in Phoenix, Arizona, USA.

  • Dr. Allen Oliff, MD

    Oncology & Drug Development

    Former Director and Head of Cancer Research at Merck. Former SVP of Drug Discovery at DuPont Pharmaceuticals. Former SVP and Head of the Center of Excellence for Drug Discovery at GSK.

  • Dr. Tawanda Gumbo, MD

    Infectious Disease

    Founder & CEO, Praedicare Inc. ; Former Director, Center for Infectious Diseases Research and Experimental Therapeutics, Baylor University, Dallas, Texas, USA.

  • Michael Slater

    Regulatory

    Former Senior Vice President, Global Regulatory Affairs and Quality Systems at LEAF4Life, Inc., L.E.A.F. Pharmaceuticals and Merrimack. Previously VP of Regulatory Affairs for Millenium and Biogen.

  • Dr. Peter Nara, D.V.M., PhD, F.A.A.A.S

    Former Section Chief National Cancer Institute, Co-founder Lantern Pharma Inc.-first of the Precision Oncology companies using AI in target drug discovery and development and elected Medical Fellow to the American Association for the Advancement of Science.

  • Michael G. Trachtman, JD

    Over 40 years advising businesses on litigation, employment law, trade secrets, and transactions. Former adjunct professor at Villanova Law, published author, and outside general counsel for the MidAtlantic Employers' Association.